glp 1 agonist mechanism Glucagon-like peptide receptor agonists: cardiovascular benefits and mechanisms of action The use of GLP-1: receptor

Last June at a conference, I was struck by a comment from one of the speakers who talked about the importance of getting away from the current National Sickness Service back to the true ideal of a National Health Service treating patients holistically, focusing on prevention and not just cure, and long-term joint responsibility with the patient for wellness and well-being

doi: 10.3390/toxins13070452 Jiang, Yan, Castro, Joel, Blomster, Linda V., Agwa, Akello J., Maddern, Jessica, Schober, Gudrun, Herzig, Volker, Chow, Chun Yuen, Cardoso, Fernanda C., Demtrio De Souza Frana, Paula, Gonzales, Junior, Schroeder, Christina I., Esche, Steffen, Reiner, Thomas, Brierley, Stuart M

J Indian Med Assoc

LiAYiBHanHYangSHuZZhengLet al

Civil Engineering, UCLA Last updated: June 2026 Human-researched and AI-assisted with full editorial review